How much funding has Minutia raised?

Minutia has raised $13.5M in total funding, most recently a Grant round.

Who are Minutia's investors?

Minutia's investors include SOSV.

Where is Minutia headquartered?

Minutia is headquartered in Oakland, California, United States.

What industry is Minutia in?

Minutia operates in Biotech, Healthcare.

Minutia

A Next Generation Cell Therapy Company

Oakland, United States · Founded 2021 · $13.5M raised

Biotech

Healthcare

Headquarters: Oakland, California
Employees: 1–10
Founded: 2021
Business Model: B2B

Website: minutia.co
Total Funding: $13.5M
Last Round: $7.0M GrantSep 2021
Rounds: 2

About

Minutia is a next-generation cell therapy company working towards a functional cure for type 1 diabetes through a transplant of insulin-producing cells combined with nanosensors. The company's novel approach combines robust and controlled insulin-producing cell transplants with in vivo monitoring capability using a unique nanoparticle platform, aiming to revolutionize the clinical landscape for diabetes and cell replacement therapy. Founded by CEO Katy Digovich, who has lived with type 1 diabetes for over 30 years, Minutia is supported by non-dilutive funding from the NIH, California Institute for Regenerative Medicine (CIRM), and JDRF, and is backed by SOSV via an IndieBio cohort.

Summary

Minutia is a Biotech company based in Oakland, United States, founded in 2021. It has raised $13.5M in total across 2 rounds, most recently a $7.0M Grant round in Sep 2021. Investors include SOSV.